News

Digital & Data,Pharmaceuticals and therapeutics,Therapeutic Areas
Tris Pharma partners with Calm Health and ADHD Central to support patients
read more
Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Research & Development
US FDA inspects Aurisco site for generic oligonucleotide manufacturing
read more
Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development
Remepy raises $36M to advance Parkinson’s drug into Phase 3
read more
Manufacturing & Supply Chain
University Hospital Cologne selects Celonic for anti-Pseudomonas antibody manufacturing
read more
Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Research & Development
Tufts analysis finds AI clinical monitoring could cut trial costs and development time
read more
Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain,Research & Development
CN Bio wins Innovate UK grant to develop human-relevant drug testing workflow
read more
Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
FDA grants Priority Review to Belite Bio’s tinlarebant for Stargardt disease
read more
Advanced Therapies,Clinical & Regulatory,Genomics and sequencing,Research & Development,Therapeutic Areas
Skylark Bio doses first patient in Phase 1/2 trial for GJB2-related deafness
read more
Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development
CellProthera and Alfresa sign MOU for ProtheraCytes Phase 3 trial in Japan
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
FDA approves Moderna’s mRNA flu vaccine mFLUSIVA
read more
Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Vaderis raises $152M and starts Phase 3 trial of engasertib in HHT
read more
Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
AC Immune gets FDA Fast Track for Parkinson’s immunotherapy ACI-7104
read more
Biotech & Pharma Business,Digital & Data,Genomics and sequencing,Research & Development,Therapeutic Areas
Bios Life launches with $25M funding and Tempus cancer AI partnership
read more
Drug Delivery & Formulation,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Calla Lily selected for $50M Wellcome Leap antibiotic programme
read more
Advanced Therapies,Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Oncoinvent publishes Radspherin dosimetry data in Journal of Nuclear Medicine
read more
Central Nervous System,Genomics and sequencing,Research & Development,Therapeutic Areas
Alamar expands Alzheimer’s proteomics partnership with 86,000 more samples
read more

Tris Pharma partners with Calm Health and ADHD Central to support patients

US FDA inspects Aurisco site for generic oligonucleotide manufacturing

Remepy raises $36M to advance Parkinson’s drug into Phase 3

University Hospital Cologne selects Celonic for anti-Pseudomonas antibody manufacturing

Tufts analysis finds AI clinical monitoring could cut trial costs and development time

CN Bio wins Innovate UK grant to develop human-relevant drug testing workflow

FDA grants Priority Review to Belite Bio’s tinlarebant for Stargardt disease

Skylark Bio doses first patient in Phase 1/2 trial for GJB2-related deafness

CellProthera and Alfresa sign MOU for ProtheraCytes Phase 3 trial in Japan

FDA approves Moderna’s mRNA flu vaccine mFLUSIVA

Vaderis raises $152M and starts Phase 3 trial of engasertib in HHT

AC Immune gets FDA Fast Track for Parkinson’s immunotherapy ACI-7104

Bios Life launches with $25M funding and Tempus cancer AI partnership

Calla Lily selected for $50M Wellcome Leap antibiotic programme

Oncoinvent publishes Radspherin dosimetry data in Journal of Nuclear Medicine

Alamar expands Alzheimer’s proteomics partnership with 86,000 more samples

main menu

recent posts

FDA grants De Novo authorisation to Avulux migraine light-sensitivity lens

Oxford research to explore AI stroke prediction from routine cardiac CT at ESC 2026

Robotic gastrectomy shows benefits over laparoscopic surgery in gastric cancer

get connected